Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gazzard

Showing results (141-150 of 373) with videos related to

Pageof 38
Sort By:
Gut|October 1, 1974
Proceedings: Fulminant hepatic failure: histological quantitation of surviving liver parenchyma in the evaluation of the cause of deathB Portmann, B G Gazzard, I M Murray-Lyon, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1992
The pharmacokinetics of oral itraconazole in AIDS patientsD Smith, V van de Velde, R Woestenborghs, et al.
The Quarterly Journal of Medicine|March 1, 1991
Abdominal pain in HIV infectionP J Thuluvath, G M Connolly, A Forbes, et al.
AIDS (London, England)|August 16, 2001
Cessation of secondary prophylaxis in patients with cryptococcosisN C Nwokolo, M Fisher, B G Gazzard, et al.
The British Journal of Ophthalmology|February 25, 2003
Utility values and myopia in teenage school studentsS-M Saw, G Gazzard, K-G Au Eong, et al.
Drugs|April 8, 1998
Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and useG J Moyle, B G Gazzard, D A Cooper, et al.
Journal of Clinical Pathology|February 1, 1993
Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumoniaT R Leigh, B G Gazzard, A Rowbottom, et al.
AIDS (London, England)|March 2, 2002
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphomaTom Powles, Nesrina Imami, Mark Nelson, et al.
Postgraduate Medical Journal|May 1, 1985
Chronic dyspepsia pain in general practice--its causes and diagnosisP Lance, S Gibson-Glubb, J A Gazzard, et al.
The Quarterly Journal of Medicine|March 1, 1993
The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)G J Moyle, M R Nelson, D Hawkins, et al.
Pageof 38

Showing results (141-150 of 373) with videos related to

Sort By:
Pageof 38
Gut|October 1, 1974
Proceedings: Fulminant hepatic failure: histological quantitation of surviving liver parenchyma in the evaluation of the cause of deathB Portmann, B G Gazzard, I M Murray-Lyon, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1992
The pharmacokinetics of oral itraconazole in AIDS patientsD Smith, V van de Velde, R Woestenborghs, et al.
The Quarterly Journal of Medicine|March 1, 1991
Abdominal pain in HIV infectionP J Thuluvath, G M Connolly, A Forbes, et al.
AIDS (London, England)|August 16, 2001
Cessation of secondary prophylaxis in patients with cryptococcosisN C Nwokolo, M Fisher, B G Gazzard, et al.
The British Journal of Ophthalmology|February 25, 2003
Utility values and myopia in teenage school studentsS-M Saw, G Gazzard, K-G Au Eong, et al.
Drugs|April 8, 1998
Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and useG J Moyle, B G Gazzard, D A Cooper, et al.
Journal of Clinical Pathology|February 1, 1993
Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumoniaT R Leigh, B G Gazzard, A Rowbottom, et al.
AIDS (London, England)|March 2, 2002
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphomaTom Powles, Nesrina Imami, Mark Nelson, et al.
Postgraduate Medical Journal|May 1, 1985
Chronic dyspepsia pain in general practice--its causes and diagnosisP Lance, S Gibson-Glubb, J A Gazzard, et al.
The Quarterly Journal of Medicine|March 1, 1993
The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)G J Moyle, M R Nelson, D Hawkins, et al.
Pageof 38